Cyclooxygenase InhibitorsLactonesCyclooxygenase 2Cyclooxygenase 2 InhibitorsSulfonesCyclooxygenase 1IndomethacinProstaglandin-Endoperoxide SynthasesAnti-Inflammatory Agents, Non-SteroidalIbuprofenDinoprostoneProstaglandinsDiclofenacLipoxygenase InhibitorsPyrazolesArachidonic AcidPiroxicamNaproxenSafety-Based Drug WithdrawalsSulfonamidesMasoprocolIsoenzymesFlurbiprofenArachidonic AcidsMeclofenamic AcidThromboxane B2ThiazinesNitrobenzenesAspirinLipoxygenaseEpoprostenol6-Ketoprostaglandin F1 alphaEicosanoids5,8,11,14-Eicosatetraynoic AcidTolmetinReceptors, Prostaglandin E4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineMembrane ProteinsThromboxane A2Dose-Response Relationship, DrugVasodilationProstaglandins EThromboxane-A SynthaseThromboxanesBradykininDinoprostNG-Nitroarginine Methyl EsterLeukotrienesHydroxyeicosatetraenoic AcidsEnzyme InhibitorsNitric OxideArachidonate 5-Lipoxygenase8,11,14-Eicosatrienoic AcidIndoprofenAnalgesics, Non-NarcoticKetorolacVasoconstrictionQuinacrineRats, Sprague-DawleySulindacLeukotriene B4Endothelium, VascularProstaglandin AntagonistsArachidonate LipoxygenasesRats, WistarAlprostadilPhospholipases AClinical Trials, Phase IV as TopicKetoprofenNitric Oxide SynthaseBiological FactorsPhospholipases A2Endothelium-Dependent Relaxing FactorsOsteoarthritisAcetylcholineReceptors, ThromboxaneVasodilator AgentsVasoconstrictor AgentsAcetaminophenAcetophenonesHydrazinesCalcimycinArteriolesGastrointestinal Diseases15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidDrug InteractionsProstaglandin D2NitroarginineBlood PlateletsCells, CulturedReceptors, Prostaglandin E, EP2 SubtypeReceptors, Prostaglandin E, EP4 SubtypeGastric MucosaSRS-ARabbitsProstaglandins FProstaglandins E, SyntheticMuscle, Smooth, VascularIsodesmosineMesenteric Arteries